Investigation of Hepatic Tumors with Positron Emission Tomography Using [11C]-Metomidate and [11C]-Acetate Tracers

Organisation name was not entered0 个研究点开始时间: 2004年8月5日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Patients with incidentally detected liver masses (CT/MRI/US) or liver metastasis and known primary tumor who have not received oncologic treatment.
•Patients must be in physical and psychological condition which allows them to participate to the study.
•Patients must give written informed consent.
•The histology of liver tumors will be confirmed
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Treatments which might affect tracer binding to 11?-hydroxylase : ketoconazole and metyrapone as well as chemotherapy.
•Vulnerable study subjects such as described in Finnish law concerning clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included. Pregnancy will be excluded in all uncertain cases of fertile female with the Predictor pregnancy test.

发起方

Organisation name was not entered